PHARMACEUTICAL TECHNOLOGY · ALBANY, NEW YORK

Rethinking ready-to-use aseptic injectable medicines.

Hovina is developing patented Blow Fill Insert Seal (BFIS) technology for large-volume, ready-to-use aseptic injectable medicines, with a focus on packaging innovation and manufacturing simplicity.

Hovina BFIS container prototype on a blue studio background
01 · THE OPPORTUNITY

Fewer preparation steps.
More possibilities for care.

Drug shortages, medication preparation requirements, and manufacturing complexity create challenges across healthcare. Hovina is exploring how packaging technology for ready-to-use aseptic medicines could help address these needs.

CARE DELIVERY

Preparation complexity

Ready-to-use aseptic presentations may reduce preparation and handling steps for suitable medicines.

SUPPLY

Manufacturing flexibility

Packaging innovation may help manufacturers explore new ways to supply aseptic injectable medicines.

PRODUCT DESIGN

Large-volume formats

Hovina is developing BFIS for large-volume aseptic injectable applications, including heat-sensitive drug products.

02 · THE TECHNOLOGY

Meet Blow Fill Insert Seal.

BFIS is Hovina’s patented packaging technology platform under development for large-volume, ready-to-use aseptic injectable medicines, including heat-sensitive products.

The platform brings together container design and pharmaceutical manufacturing considerations. Product suitability and manufacturing performance depend on further development, evaluation, and validation.

BFIS PLATFORM

An integrated packaging concept

Designed to support ready-to-use aseptic injectable products through a differentiated container and manufacturing approach.

High-level overview only. Detailed technical information is available through appropriate confidential discussions.

03 · VALUE PROPOSITION

Designed with safety, efficiency and availability in mind.

BFIS is being developed around three priorities for pharmaceutical manufacturers and healthcare users.

01 · ECONOMICS

Manufacturing simplicity

A packaging approach intended to simplify aspects of pharmaceutical manufacturing and support efficient production.

02 · SPEED

Development and scale-up

A platform designed with scalable development and future manufacturing needs in mind.

03 · EXPERIENCE

Preparation and handling

Ready-to-use aseptic medicines may reduce preparation steps for suitable formulations and support simpler administration workflows.

04 · ABOUT HOVINA

Pharmaceutical packaging innovation from Albany, New York.

Based in Albany, New York, Hovina is developing BFIS technology for large-volume, ready-to-use aseptic injectable medicines. We welcome discussions with pharmaceutical manufacturers, development organizations and strategic partners interested in exploring potential applications and collaboration.

LET'S CONNECT

Explore what BFIS could make possible.

Hovina welcomes confidential discussions with pharmaceutical manufacturers, development partners, and organizations interested in evaluating BFIS technology, potential product applications, and strategic collaboration opportunities. Additional technical information may be shared under an appropriate confidentiality agreement.

Jeff Hover · Founder · Hovina Inc.